Postpartum Hypertension: Implications for Recurrent Hypertensive Disorders and Exploration of Modifiable Intermediates - PROJECT SUMMARY Hypertensive disorders of pregnancy (HDP), such as preeclampsia, affect more than 10% of all pregnancies in the United States and are associated with increased risks of future cardiovascular disease (CVD). These disorders are recurrent, thereby increasing the risk of HDP in subsequent pregnancies, and further elevating future CVD risk. While risk mitigation strategies for longer term development of CVD exist, the only evidence-based intervention focused on decreasing the incidence of recurrent HDP is low-dose aspirin prophylaxis initiated early in the subsequent pregnancy. Prevention strategies implemented early in pregnancy rely on timely pregnancy recognition, prenatal care initiation, and health care engagement. On the contrary, the postpartum period, or the earliest part of an interpregnancy interval, presents an opportunity to optimize health upstream of subsequent pregnancies. During the postpartum period, hypertension is a common complication affecting approximately 50% of patients with a pregnancy complicated by HDP. It has been demonstrated that early postpartum blood pressure control results in improvements in cardiovascular structure and function, but there are limited data on the impact of postpartum hypertension on subsequent HDP. Therefore, understanding the role of postpartum hypertension and its attenuating factors, such as timely capture and management, and cardioprotective behaviors such as breastfeeding, is a potential pathway to mitigate HDP recurrence. Boston Medical Center (BMC), a large safety-net hospital, is ideally suited to examine postpartum hypertension given that nearly 30% of obstetric patients experience hypertension before or during pregnancy and >90% of patients return for care within a year following delivery, allowing for the construction of a longitudinal, medical-record based cohort. In 2020, there was institution wide implementation of a postpartum home blood pressure monitoring program (HBPM) which enhanced the capture and management of postpartum hypertension among patients with HDP. This proposal will focus on patients with at least two deliveries (≥ 20 weeks of gestation) between 2016-2025, to conduct the following aims (1) estimate the association between postpartum hypertension and recurrent HDP among those with HDP in the index delivery; (2) assess the role of breastfeeding in relation to recurrent HDP among those with and without postpartum hypertension; and (3) explore the population impact of the HBPM program, as well as changes in blood pressure targets for treatment, on recurrent HDP. The ultimate goal of this research is to harness existing data on more than 1,000 patients using electronic medical record data, enhanced with blood pressure monitoring data, to guide the development of individual and systems level interventions that ultimately interrupt the cascade of pregnancy related cardiovascular complications.